Stereotactic Prostate Radiation Therapy with Simultaneous Moderate Dose Escalation to the Dominant Intraprostatic Lesion: A Dosimetric Study

被引:0
|
作者
Yu, S. [1 ]
Mathew, J. [1 ]
Dyer, M. [1 ]
Bloch, B. N. [1 ]
Hirsch, A. E. [1 ]
机构
[1] Boston Univ, Med Ctr, Boston, MA USA
关键词
D O I
10.1016/j.ijrobp.2019.06.733
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3815
引用
收藏
页码:E777 / E778
页数:2
相关论文
共 50 条
  • [21] Sculpting Dose Inhomogeneity with Consideration of the Dominant Intraprostatic Lesion in Prostate SBRT: A Planning Feasibility Study
    Hollis, E. S.
    Lawrence, M. V.
    Schreiber, E. C.
    Sud, S.
    Wijetunga, N. A.
    Repka, M. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E137 - E137
  • [22] Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).
    Deodato, Francesco
    Ferro, Milena
    Bonome, Paolo
    Pezzulla, Donato
    Romano, Carmela
    Buwenge, Milly
    Cilla, Savino
    Morganti, Alessio Giuseppe
    Macchia, Gabriella
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (3) : 239 - 249
  • [23] Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts
    Goodman, Christopher D.
    Fakir, Hatim
    Pautler, Stephen
    Chin, Joseph
    Bauman, Glenn S.
    ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (02) : 212 - 220
  • [24] VMAT-SIB boost to the dominant intraprostatic lesion: preliminary results of a dose escalation trial
    Bonome, P.
    Macchia, G.
    Ferro, M.
    Cilla, S.
    Romano, C.
    Re, A.
    Picardi, V.
    Boccardi, M.
    Pezzulla, D.
    Cammelli, S.
    Buwenge, M.
    Tagliaferri, L.
    Morganti, A. G.
    Morganti, A.
    Valentini, V.
    Deodato, F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1089 - S1090
  • [25] Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer
    Abe, Eisuke
    Mizowaki, Takashi
    Norihisa, Yoshiki
    Narita, Yuuichirou
    Matsuo, Yukinori
    Narabayashi, Masaru
    Nagata, Yasushi
    Hiraoka, Masahiro
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2010, 11 (04): : 144 - 154
  • [26] PARAMETERS FAVORABLE TO INTRAPROSTATIC RADIATION DOSE ESCALATION IN MEN WITH LOCALIZED PROSTATE CANCER
    Housri, Nadine
    Ning, Holly
    Ondos, John
    Choyke, Peter
    Camphausen, Kevin
    Citrin, Deborah
    Arora, Barbara
    Shankavaram, Uma
    Kaushal, Aradhana
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (02): : 614 - 620
  • [27] Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion
    Fonteyne, Valerie
    Villeirs, Geert
    Speleers, Bruno
    De Neve, Wilfried
    De Wagter, Carms
    Lumen, Nicolas
    De Meerleer, Gert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 799 - 807
  • [28] Dosimetric Constraints in Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: Capacity for Dose Escalation
    Peng, L. C.
    Cheng, Z.
    Rosati, L. M.
    Narang, A.
    Chen, L.
    Moore, J.
    Hooker, T.
    Jackson, J.
    Herman, J. M.
    McNutt, T. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E623 - E623
  • [29] Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study
    Ong, Ashley Li Kuan
    Knight, Kellie
    Panettieri, Vanessa
    Dimmock, Mathew
    Tuan, Jeffrey Kit Loong
    Tan, Hong Qi
    Wright, Caroline
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] Experimental assessments of intrafractional prostate motion on sequential and simultaneous boost to a dominant intraprostatic lesion
    Abdellatif, Ady
    Craig, Jeff
    Jensen, Michael
    Mulligan, Matt
    Mosalaei, Homeira
    Bauman, Glenn
    Chen, Jeff
    Wong, Eugene
    MEDICAL PHYSICS, 2012, 39 (03) : 1505 - 1517